Cargando…
Plasma extrachromosomal circular DNA is a pathophysiological hallmark of short‐term intensive insulin therapy for type 2 diabetes
BACKGROUND: Extrachromosomal circular DNA (eccDNA) has emerged as a promising biomarker for disease diagnosis and prognosis prediction. However, its role in type 2 diabetes remains unexplored. OBJECTIVE: To investigate the characteristics and dynamics of circulating eccDNAs in newly diagnosed type 2...
Autores principales: | Xu, Zhe, He, Junyu, Han, Peng, Dai, Peiji, Lv, Wei, Liu, Nian, Liu, Liyi, Liu, Liehua, Pan, Xiaoguang, Xiang, Xi, Li, Hanbo, Ge, Fangfang, Gao, Shan, Liao, Zhihong, Luo, Yonglun, Li, Yanbing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587738/ https://www.ncbi.nlm.nih.gov/pubmed/37859516 http://dx.doi.org/10.1002/ctm2.1437 |
Ejemplares similares
-
Circle‐Seq reveals genomic and disease‐specific hallmarks in urinary cell‐free extrachromosomal circular DNAs
por: Lv, Wei, et al.
Publicado: (2022) -
The effect of short‐term intensive insulin therapy on inflammatory cytokines in patients with newly diagnosed type 2 diabetes
por: He, Junyu, et al.
Publicado: (2022) -
Deciphering extrachromosomal circular DNA in Arabidopsis
por: Wang, Keyi, et al.
Publicado: (2021) -
Characterization of Plasma Extrachromosomal Circular DNA in Gouty Arthritis
por: Pang, Jingyuan, et al.
Publicado: (2022) -
Extrachromosomal Circular DNA: A New Target in Cancer
por: Wu, Pan, et al.
Publicado: (2022)